1. Home
  2. PRME vs WLAC Comparison

PRME vs WLAC Comparison

Compare PRME & WLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • WLAC
  • Stock Information
  • Founded
  • PRME 2019
  • WLAC 2024
  • Country
  • PRME United States
  • WLAC United States
  • Employees
  • PRME N/A
  • WLAC N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • WLAC
  • Sector
  • PRME Health Care
  • WLAC
  • Exchange
  • PRME Nasdaq
  • WLAC Nasdaq
  • Market Cap
  • PRME 191.7M
  • WLAC 172.6M
  • IPO Year
  • PRME 2022
  • WLAC 2024
  • Fundamental
  • Price
  • PRME $3.57
  • WLAC $10.27
  • Analyst Decision
  • PRME Buy
  • WLAC
  • Analyst Count
  • PRME 6
  • WLAC 0
  • Target Price
  • PRME $8.88
  • WLAC N/A
  • AVG Volume (30 Days)
  • PRME 4.4M
  • WLAC 12.2K
  • Earning Date
  • PRME 08-07-2025
  • WLAC 01-01-0001
  • Dividend Yield
  • PRME N/A
  • WLAC N/A
  • EPS Growth
  • PRME N/A
  • WLAC N/A
  • EPS
  • PRME N/A
  • WLAC N/A
  • Revenue
  • PRME $4,961,000.00
  • WLAC N/A
  • Revenue This Year
  • PRME $126.92
  • WLAC N/A
  • Revenue Next Year
  • PRME $87.32
  • WLAC N/A
  • P/E Ratio
  • PRME N/A
  • WLAC $732.58
  • Revenue Growth
  • PRME 739.42
  • WLAC N/A
  • 52 Week Low
  • PRME $1.11
  • WLAC $9.80
  • 52 Week High
  • PRME $5.17
  • WLAC $10.60
  • Technical
  • Relative Strength Index (RSI)
  • PRME 46.93
  • WLAC N/A
  • Support Level
  • PRME $3.35
  • WLAC N/A
  • Resistance Level
  • PRME $3.88
  • WLAC N/A
  • Average True Range (ATR)
  • PRME 0.38
  • WLAC 0.00
  • MACD
  • PRME -0.12
  • WLAC 0.00
  • Stochastic Oscillator
  • PRME 16.00
  • WLAC 0.00

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About WLAC Willow Lane Acquisition Corp. Class A Ordinary Shares

Willow Lane Acquisition Corp is a blank check company.

Share on Social Networks: